AI could reduce pharma R&D costs by 30% to 40% and shorten timelines by one to four years. The partnership expands Lilly’s existing AI supercomputer project with Nvidia’s DGX technology. Follow 24/7 ...

During CES 2025, NVIDIA spent much of its keynote touting its leading position in artificial intelligence. Still, the company managed to squeeze in a few notable hardware announcements, including its ...

It was just three months ago that Nvidia turned heads in the tech world with the DGX Spark, a $4,000 desktop supercomputer that was meant to help democratize AI beyond corporate giants. Things move ...

Eli Lilly (LLY) and Nvidia (NVDA) will invest up to $1B over five years in an AI drug discovery lab. AI could reduce pharma R&D costs by 30% to 40% and shorten timelines by one to four years. The ...